Are we beginning to see evidence of ‘Antibody Dependent Enhancement’ (ADE) due to the Covid-19 vaccines in the United Kingdom? The latest data on hospitalisations and deaths allegedly due to Covid-19 certainly suggests so.

ADE can arise in several different ways but the best-known is dubbed the ‘Trojan Horse Pathway’. This occurs when non-neutralizing antibodies generated by past infection or vaccination fail to shut down the pathogen upon re-exposure.

Instead, they act as a gateway by allowing the virus to gain entry and replicate in cells that are usually off limits (typically immune cells, like macrophages). That, in turn, can lead to wider dissemination of illness, and over-reactive immune responses that cause more severe illness.

Barry Bloom, MD, PhD, of the Harvard T.H. Chan School of Public Health explanation of ADE is as follows –

“The cause of ADE is having antibodies to a virus that don’t neutralize it. That enables the virus to be gobbled up by cells that have receptors for antibodies, but not the virus. That’s the way of getting virus into cells that it ordinarily would not infect,”.

ADE can also occur when neutralizing antibodies (which bind the virus and stop it from causing infection) are present at low enough levels that they don’t protect against infection. Instead, they can form immune complexes with viral particles, which in turn leads to worse illness.

In 2016, a dengue virus vaccine was designed to protect against all four serotypes of the virus. The hope was that by inducing immune responses to all four serotypes at once, the vaccine could circumvent the issues related to ADE following disease with dengue virus. The vaccine was given to children in the Philippines. However, fourteen vaccinated children died after encountering dengue virus in the community as they had developed antibody responses that were not capable of neutralizing the natural virus circulating in the community.

In previous clinical trials of vaccine candidates to combat SARS and MERS, the studies each failed during the animal phase due to ADE also known as pathogenic priming or a cytokine storm.

Phase three clinical trials are designed to uncover frequent or severe side effects before a vaccine is approved for use, including ADE.

But here in lies the problem, none of the Covid-19 vaccines have completed phase three clinical trials.

The Pfizer phase three trial is not due to complete until April 6th 2023.

Whilst the AstraZeneca phase three trial is due to complete slightly earlier on February 14th 2023.

This means that the current worldwide Covid vaccine roll-out can be described as the largest human experiment ever conducted in history. Anybody who takes this vaccine, which is only temporarily authorised for emergency use is essentially a lab rat taking part in a trial.

We are learning the effects of these new “vaccines” that allegedly combat Covid-19 in the real world, not a single person has any idea what the long term consequences may be. But we do know some of the short term consequences.

According to the MHRA Yellow Card reports as of the 9^th June 2021 there have been 949,287 adverse reactions reported alongside 1,332 deaths. However only 1% – 10% of adverse reactions are reported and the MHRA state that 1 in every 142 people are suffering an adverse reaction. But in reality the actual rate could be as high as anywhere between 1 in every 14 people or 2 in every 3 people.

The adverse reactions suffered are not just things like a sore arm, or a headache. They include things like blindness, seizure, paralysis, brain damage, and stroke, and now we may be seeing evidence of antibody dependant enhancement courtesy of the latest data published by Public Health England on variants of concern in England.

The published government document which can be viewed here presents data within a table found on page 12 showing ‘Attendance to emergency care and deaths by vaccination status among Delta confirmed cases in England, 1^st February 2021 to 14^th June 2021’.

As you can see in the table since the 1^st February 2021 there have been 60,624 alleged positive cases of the Delta Covid variant, but only 58.5% of these cases occurred in people who had not had the Covid vaccine. 4,087 of them occurred in people who were fully vaccinated, and 9,461 occurred in people who’d had a single dose of a Covid vaccine at least 21 days prior to allegedly being infected with Covid-19.

But here’s where things get both interesting and concerning. Since the 1^st February 2021 there have been 73 alleged Covid deaths within 28 days of a positive test result due to the Delta Covid variant. However only 46.5% of these deaths were people who had not been vaccinated. Whilst 36.6% of the deaths were people who had been fully vaccinated for at least two weeks. A further 13.7% of the deaths were people who’d had one dose of a Covid vaccine at least 21 days prior to infection.

In all 50.68% of the deaths occurred in people who had received at least one dose of the Covid-19 vaccine. A further two deaths occurred in which Public Health England had not ascertained whether the person had received a dose of the Covid vaccine.

There are multiple conclusions we can come to due to this data –

1 – These people did not die to Covid-19 but instead died due to other causes and were just labelled as Covid-19 because they happened to test positive 28 days prior to their death.

2 – The vaccines do not work.

3 – The vaccines are causing antibody dependant enhancement, as has been proven to happen in trials for SARS and MERS vaccine candidates.

But there is further evidence the vaccines are causing serious issues in the wider population.

A&E departments across the UK are currently at breaking point with record numbers of patients seeing numbers rise up by 50% compared with levels seen prior to the alleged pandemic.

At least 30 hospitals across England have seen record levels of patients during June, stretching from Exeter and Plymouth in the south to hospitals in Middlesbrough, Manchester and elsewhere in the north of England.

On Tuesday, the North Middlesex Hospital in north London declared an internal incident after 700 patients attended its A&E department – the highest level since January 2020, when 684 were recorded in a single day.

The University Hospitals of Leicester trust also recorded its busiest day ever on Tuesday, with 925 patients, as did the University Hospitals of North Midlands trust in Stoke, which saw 866 patients.

---

---

At the University Hospitals Birmingham trust, which runs three A&E departments in the region, attendances have jumped from an average of around 900 per day in December 2019 to 1,350 this month. One clinician at the trust said patients were waiting at least nine hours to be seen on some occasions.

At Leeds General Infirmary, the average daily attendance was 350 before the pandemic but has now exceeded 400 patients a day. The trust has publicly warned patients on its Facebook page that they face long waits.

At the Royal Liverpool Hospital the A&E department was described as “at full stretch” with the situation labelled “unsustainable” by one consultant.

Other hospitals declaring record demand include the Royal Free in London, Addenbrooke’s Hospital in Cambridge, and the John Radcliffe Hospital in Oxford.

Pressure is also being felt by paramedics. In a leaked briefing to West Midlands Ambulance Service staff, the trust said the problem of delays at hospital was now “the biggest risk to patient safety”.

“Seven of the top 10 busiest days the trust has experienced from a call perspective have come in June 2021! The situation is quite unprecedented and is being repeated across the country.”

For the first two weeks of the month, calls rose 30 per cent compared to the same month in 2019,

The briefing said – “The trust has not seen sustained pressure like it is currently experiencing in a very long time, if ever. Hospital delays are extensive and growing; members of the public are getting angry at delays in ambulances arriving and are taking it out on staff over the phone and in person.”

We must question why A&E departments across the country would be breaking records for attendance in June, when the highest month of attendance is usually January. Could it be something to do with the fact that as of the 20^th June 2021, 35 million people in England have had at least one dose of an experimental vaccine and the consequences of their decisions are beginning to be realised?

Are we beginning to see evidence of Antibody Dependent Enhancement? It’s hard to tell due to the fact we are in the middle of Summer, a season which throughout history has kept respiratory viral infections at bay. We will find out once Winter arrives, and it is only a few short months away, but we’ve a feeling based on the evidence that it isn’t going to be pretty.